Fluticasone, umeclidinium, and vilanterol Inhalation and Synjardy

• Generic Name: fluticasone / umeclidinium / vilanterol
• Dosage Forms: n.a.
• Other Brand Names: Trelegy Ellipta

Fluticasone, umeclidinium, and vilanterol combination is used to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is used long term to improve breathing problems and to reduce the number of COPD flare-ups (worsening of your COPD symptoms for several days). Fluticasone, umeclidinium, and vilanterol will not relieve a COPD attack that has already started.

Inhaled fluticasone belongs to the family of medicines known as corticosteroids or steroids (cortisone-like medicines). It works by preventing certain cells in the lungs and breathing passages from releasing substances that cause COPD symptoms.

Inhaled umeclidinium and vilanterol are long-acting bronchodilators. These are medicines that are breathed in through the mouth to open up the bronchial tubes (air passages) in the lungs. They relieve cough, wheezing, shortness of breath, and troubled breathing by increasing the flow of air through the bronchial tubes.

Fluticasone, umeclidinium, and vilanterol is available only with your doctor's prescription.

• Generic Name: empagliflozin / metformin
• Dosage Forms: tablet
• Other Brand Names: Synjardy, Synjardy XR

Synjardy contains a combination of empagliflozin and metformin. Empagliflozin and metformin are oral diabetes medicines that help control blood sugar levels. Empagliflozin works by helping the kidneys get rid of glucose from your bloodstream. Metformin lowers glucose production in the liver and also causes your intestines to absorb less glucose.

Synjardy is used together with diet and exercise to improve blood sugar control in adults with diabetes mellitus.

Synjardy is also used to lower the risk of death from heart attack, stroke, or heart failure in adults with type 2 diabetes who also have heart disease.

Synjardy is not for treating type 1 diabetes.